Puma Biotechnology Inc (PBYI)
5.18
+0.17
(+3.39%)
USD |
NASDAQ |
Apr 22, 16:00
5.18
0.00 (0.00%)
Pre-Market: 20:00
Puma Biotechnology Accounts Payable (Quarterly): 6.889M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.889M |
September 30, 2023 | 5.061M |
June 30, 2023 | 7.795M |
March 31, 2023 | 8.589M |
December 31, 2022 | 6.44M |
September 30, 2022 | 14.93M |
June 30, 2022 | 9.841M |
March 31, 2022 | 7.412M |
December 31, 2021 | 11.17M |
September 30, 2021 | 20.05M |
June 30, 2021 | 11.17M |
March 31, 2021 | 10.65M |
December 31, 2020 | 12.08M |
September 30, 2020 | 12.53M |
June 30, 2020 | 11.77M |
March 31, 2020 | 17.27M |
December 31, 2019 | 19.18M |
September 30, 2019 | 9.056M |
June 30, 2019 | 15.07M |
March 31, 2019 | 28.88M |
December 31, 2018 | 20.68M |
September 30, 2018 | 16.36M |
June 30, 2018 | 22.34M |
March 31, 2018 | 23.56M |
December 31, 2017 | 27.69M |
Date | Value |
---|---|
September 30, 2017 | 17.64M |
June 30, 2017 | 24.67M |
March 31, 2017 | 23.97M |
December 31, 2016 | 20.04M |
September 30, 2016 | 20.88M |
June 30, 2016 | 24.62M |
March 31, 2016 | 24.84M |
December 31, 2015 | 17.80M |
September 30, 2015 | 9.783M |
June 30, 2015 | 10.44M |
March 31, 2015 | 12.61M |
December 31, 2014 | 15.00M |
September 30, 2014 | 18.45M |
June 30, 2014 | 18.80M |
March 31, 2014 | 15.19M |
December 31, 2013 | 10.69M |
September 30, 2013 | 9.73M |
June 30, 2013 | 7.624M |
March 31, 2013 | 6.887M |
December 31, 2012 | 0.482M |
September 30, 2012 | 1.018M |
June 30, 2012 | 2.41M |
March 31, 2012 | 0.5667M |
December 31, 2011 | 0.087M |
September 30, 2011 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.061M
Minimum
Sep 2023
20.05M
Maximum
Sep 2021
11.42M
Average
11.17M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
ADMA Biologics Inc | 15.66M |
Regeneron Pharmaceuticals Inc | 606.60M |
Sarepta Therapeutics Inc | 164.92M |
CytomX Therapeutics Inc | 1.458M |
Mirum Pharmaceuticals Inc | 7.416M |